According to the latest report by IMARC Group, titled "Licorice Extract Market Report by Product Type (Food Grade, Feed Grade, Pharmaceutical Grade), Form (Block, Powder, Paste, and Others), Application (Food and Beverages, Pharmaceutical, Tobacco, and Others), and Region 2025-2033," the global licorice extract market reached a value of USD 2,169.4 Million in 2024. Licorice extract refers to a herbal extract derived from the Glycyrrhiza glabra plant that is generally grown in certain parts of Western Asia and Southern Europe. It is traditionally used to treat multiple diseases due to its anti-cancer, anti-inflammatory, antioxidant and antimicrobial properties. It is widely used as a medicine for treating eczema, mouth sores, and bacterial and viral infections. Additionally, it is commonly available in the form of syrups or capsules, which assist in elevating the mucous coating of the esophageal lining to resist the irritating effects of stomach acid.
Global Licorice Extract Market Trends:
The global market is primarily driven by the increasing utilization of the product in the manufacturing of medicines and health supplements. Along with this, the rising health consciousness among individuals and their changing dietary preferences is providing a thrust to the market growth. This has impelled leading manufacturers to utilize licorice extract as a natural sweetener and food additive across the food and beverages industry, thereby providing a boost to the market growth. Moreover, the increasing adoption of the product in the formulation of multiple skincare products that help in accelerating the wound epithelization and reducing the symptoms of atopic dermatitis is acting as a major growth-inducing factor. Other factors, including the widespread product adoption as a de-bittering agent across the tobacco industry and extensive research and development (R&D) activities conducted by key players, are further contributing to the market growth. Looking forward, the market value is projected to reach USD 3,299.5 Million by 2033, expanding at a CAGR of 4.53% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Product Type, Form, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Alfarid Corporation Limited, AOS Products Pvt. Ltd., Avestia Pharma, C.E. Roeper GmbH, F&C Licorice Ltd., Herbochem, Hyundai Bioland, Mafco Worldwide LLC, Maruzen Pharmaceuticals Co. Ltd., Norevo GmbH, Shaanxi FUJIE Pharmaceutical Co. Ltd. and VPL Chemicals Pvt Ltd. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800